HIGJX
Price
$21.73
Change
+$0.08 (+0.37%)
Updated
Aug 13 closing price
Net Assets
523.71M
RMFCX
Price
$60.24
Change
+$0.18 (+0.30%)
Updated
Aug 13 closing price
Net Assets
109.66B
Interact to see
Advertisement

HIGJX vs RMFCX

Header iconHIGJX vs RMFCX Comparison
Open Charts HIGJX vs RMFCXBanner chart's image
Carillon Eagle Growth & Income I
Price$21.73
Change+$0.08 (+0.37%)
VolumeN/A
Net Assets523.71M
American Funds American Mutual R3
Price$60.24
Change+$0.18 (+0.30%)
VolumeN/A
Net Assets109.66B
HIGJX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HIGJX vs. RMFCX commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIGJX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 110B vs. HIGJX (524M). HIGJX pays higher dividends than RMFCX: HIGJX (1.47) vs RMFCX (1.26). HIGJX was incepted earlier than RMFCX: HIGJX (16 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than HIGJX (0.71). HIGJX is a more actively managed with annual turnover of: 40.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than HIGJX: RMFCX (250) vs HIGJX (10000). RMFCX annual gain was more profitable for investors over the last year : 9.63 vs. HIGJX (-0.38). RMFCX return over 5 years is better than : 55.38 vs. HIGJX (12.80).
HIGJXRMFCXHIGJX / RMFCX
Total Expense Ratio0.710.9178%
Annual Report Gross Expense Ratio0.710.9178%
Fund Existence16 years23 years-
Gain YTD7.85111.03471%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets524M110B0%
Annual Yield % from dividends1.471.26117%
Returns for 1 year-0.389.63-4%
Returns for 3 years-4.2523.78-18%
Returns for 5 years12.8055.3823%
Returns for 10 years43.0079.8754%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.280.07
+5.79%
Pacific Biosciences of California
EMCG13.670.33
+2.47%
Embrace Change Acquisition Corp
BCRX8.530.18
+2.16%
BioCryst Pharmaceuticals
MTSI125.990.54
+0.43%
MACOM Technology Solutions Holdings
PCTTU17.80N/A
N/A
PureCycle Technologies